Stocks Are Too Risky. What GMO’s Inker Says to Buy Instead.

GMO’s Ben Inker gave Barron’s an exclusive on why he has dramatically reduced the $60 billion firm’s stock allocation, and where there still might be a little bit of value

https://finance.yahoo.com/m/baef0482...html?.tsrc=rss